Medicating Appetite: The GLP-1 Dilemma

At first, they were diabetes drugs.
GLP-1 receptor agonists—liraglutide, semaglutide, and later tirzepatide—were developed to help patients with type 2 diabetes regulate blood sugar. They mimicked a gut hormone, GLP-1, that modulates insulin, glucagon, and gastric emptying. They also acted on the brain.
Appetite went down.
Weight came off.
And people noticed.


Notice: Function wp_maybe_inline_styles was called incorrectly. Unable to read the "path" key with value "https://www.docsopinion.com/wp-content/plugins/jetpack/_inc/build/subscriptions/subscriptions.min.css" for stylesheet "jetpack-subscriptions". Please see Debugging in WordPress for more information. (This message was added in version 7.0.0.) in /www/docsopinion_230/public/wp-includes/functions.php on line 6170